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Hip involvement in Ankylosing Spondylitis is common and leads to physical 
and function restriction. Hip replacement surgery is a successful and effective 
treatment for end-stage hip involvement; however in Ankylosing Spondylitis 
patient’s prosthesis long-term survival is lesser than other causes of hip 
osteoarthritis. We report a case of 61-year old Ankylosing Spondylitis male 
patient with bilateral cementless hip replacement with 26-year and 25-year 
follow-up. 
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Introduction
Ankylosing Spondylitis (AS) is the prototype of Axial 
Spondyloarthritis (SpA) and is a chronic inflammatory disease of 
unknown etiology that affects mainly active young men [1]. AS is 
characterized by inflammation of the sacroiliac joints, axial spine and 
peripheral joints. Peripheral involvement has been reported between 
73% of the cases with hip being the most commonly affected joint (25-
50%) [2,3]. Hip joint and spine involvement affect patient’s ability to 
walk and leads to deterioration of their function and physical activity, 
increases the burden of the disease and its prognosis [4].
A specific treatment option in end-stage hip involvement in AS is 
the Total Hip Replacement Surgery (THR). The aims of THR are pain 
relief, increased range of motion, improved mobility and correction 
of posture. THR is a successful surgical procedure in advance hip 
osteoarthritis with long-term outcome studies demonstrating a 90% 
outcome survival at 15 to 20 years of follow-up [5]. However, THR 
survival in AS patients is lesser, being reported as 60-65% over 15 
years in best series [6-8].
The authors report a case of an AS 61-year-old patient with a 
severe disease with several joint replacements (shoulders, hips and 
right knee) with a bilateral THR with 26 and 25-year follow-up.
Case Presentation
A history of low back and cervical inflammatory pain began 40 
years ago with prolonged morning stiffness leading to AS diagnosis 
10 years later. He was under treatment with various NSAIDs. There 
was a history of dactilitis, entesitis and peripheral arthritis, but there 
was not uveitis, psoriasis or bowel inflammatory disease and he was 
HLA-B27 negative. There was syndesmophites in lumbar X-ray and 
radiological grade III bilateral sacroiliitis. Other co-morbidities were 
obesity (body mass index of 38 Kg/m2), arterial hypertension and 
dyslipidemia. 
Despite NSAID treatment the patient presented hip inflammatory 
pain with progressive limitation of hip range of motion and 
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inflammatory shoulder pain. Due to the bilateral hip osteoarthritis, 
continuous hip pain and daily life limitations, a right and left 
cementless THR were performed 26 and 25 years ago respectively. 
The bilateral THR were implanted using a standard posterior hip 
approach with the patient in lateral decubitus. THR was composed 
by an acetabular cup (RM®classiccup) and by a cementless femoral 
stem with a proximal porous coating, which allowed bone ingrowth 
into the stem.
Secondary shoulder osteoarthritis led to bilateral shoulder total 
replacement 7 and 5 years ago. Two years ago a right cemented Total 
Knee Replacement (TKR) was performed due a knee secondary 
osteoarthritis. 
Currently, he presented mechanical right knee pain and unglued 
knee prosthesis at X-ray and need a revision surgery, however the 
others prostheses are well concreted.
In the last clinical and radiological controls, at 25 and 26 years 
after the bilateral hip artroplasty, the patient was asymptomatic, the 
hip mobily were normal and the patient was very pleased with the 
functional results. Hip radiographic study showed a stable seating of 
the acetabular components, no signs of stress shielding of the proximal 
femur, no heterotopic ossification and no signs of osteolysis (Figure 
1). However, there were faint signs of wear of the left polyethylene 
cup, evidenced by a superior displacement of the metallic femoral 
head from the center of the acetabular cup.
Discussion & Conclusion
THR is considered one of the most successful interventions in 
orthopedics replacement surgery, nevertheless is not a permanent 
implant and later or earlier will failure, regardless of the hip 
osteoarthritis etiology [5]. It is known that THR in inflammatory 
rheumatism have a lower durability due to poor bone quality and 
these patients had worse preoperative status and more comorbidities 
[9]. However, in our case the result of THR was excellent because they 
survived over 20 years. Despite AS inflammatory features, there was 
Austin J Orthopade & Rheumatol 3(4): id1045 (2016)  - Page - 02
Costa C Austin Publishing Group
Submit your Manuscript | www.austinpublishinggroup.com
not any intolerance to foreign body in our AS patient. As known, the 
attrition of biomaterial prostheses particles is the source of internal 
biological reactions that lead to an osteolysis of acetabular and femoral 
bone [10]. Nevertheless, the left hip radiography shows a wear of the 
left polyethylene cup, there are no signs of osteolysis. Heterotopic 
bone formation is a well-recognized complication of THR and AS 
could be a risk factor for that, with an estimated incidence in some 
studies around 40% [11,12]. In our patient, there was not any sign of 
heterotopic bone formation. 
The RM® classic cup (isoeslastic cup of Robert Mathys, 
Switzerland) is anuncemented monoblock cup system with pure 
titanium particle coating. The coated implant is made of UHMWPE 
(Ultra High Molecular Weight Polyethylene) and had been implanted 
all over the world since 1983. Additional fixation of the acetabular 
cup can be achieved, if required, with 4 mm special screws made of 
steel or titanium.
Cemented and cementless THR have been used for the 
management of hip involvement in AS patients with good results [8]. 
Good long-term survivorship has been reported with cemented THR, 
however studies of cementless THR have shorter duration of follow-
up and therefore a conclusion of their superiority cannot be made 
[10]. The patient is currently asymptomatic and extremely pleased 
because had no complications in these 26 years and it is assumed 
that prostheses will continue to perform their function for many 
more years, although there are some signs of the left acetabular dome 
polyethylene wear, but without indication for surgical revision.
In conclusion, despite the less probability of THR durability in 
inflammatory rheumatism as AS, this is not happened in our case and 
we believe that will continue to play its role for many years.
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Figure 1: Hip radiograph made 26 years and 25 years after a cementless 
bilateral hip arthroplasty in an ankylosing spondylitis patient. The components 
of the hip prosthesis presented a solid fixation with no signs of osteolysis and 
no pain. Signs of wear of the left polyethylene cup.
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